Colgate-Palmolive Company (CL): Price and Financial Metrics
Colgate-Palmolive Company (CL)
Today's Latest Price: $69.91 USD
Updated Apr 9 12:00am
Add CL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 33 in Consumer Goods
See all "A" rated Strong Buy stocks
CL Stock Summary
- Colgate Palmolive Co's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.82% of US listed stocks.
- CL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 0.45% of US stocks.
- In terms of volatility of its share price, CL is more volatile than only 0.75% of stocks we're observing.
- Stocks that are quantitatively similar to CL, based on their financial statements, market capitalization, and price volatility, are CAH, CLMT, SPWR, XRF, and ATLC.
- Visit CL's SEC page to see the company's official filings. To visit the company's web site, go to www.colgatepalmolive.com.
CL Stock Price Chart More Charts
CL Price/Volume Stats
| Current price | $69.91 | 52-week high | $77.41 |
| Prev. close | $70.22 | 52-week low | $58.49 |
| Day low | $69.76 | Volume | 3,582,400 |
| Day high | $71.47 | Avg. volume | 5,692,945 |
| 50-day MA | $70.55 | Dividend yield | 2.46% |
| 200-day MA | $70.38 | Market Cap | 59.78B |
Colgate-Palmolive Company (CL) Company Bio
Colgate-Palmolive manufactures and markets consumer products worldwide. It operates in two segments: Oral, Personal and Home Care; and Pet Nutrition. The company was founded in 1806 and is based in New York, New York.
CL Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $69.91 | $32.5 | -54% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Colgate Palmolive Co. To summarize, we found that Colgate Palmolive Co ranked in the 25th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Colgate Palmolive Co, consider:
- Interest coverage, a measure of earnings relative to interest payments, is 22.66 -- which is good for besting 85.83% of its peer stocks (US stocks in the Consumer Defensive sector with positive cash flow).
- The business' balance sheet reveals debt to be 12% of the company's capital (with equity being the remaining amount). Approximately merely 23.53% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- CL's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 44.5% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -54% |
| 1% | -54% |
| 2% | -54% |
| 3% | -53% |
| 4% | -53% |
| 5% | -52% |
Want more companies with a valuation profile/forecast similar to that of Colgate Palmolive Co? See CORE, PG, TWNK, WMT, and KO.
Top Stories View All
Best & Worst Performing Stock Industries for April 9, 2020
Best & Worst Performing Small Cap Stocks for April 9, 2020
Best & Worst Performing Mid Cap Stocks for April 9, 2020
Best & Worst Performing Large Cap Stocks for April 9, 2020
Best & Worst Performing Mega Cap Stocks for April 9, 2020
View All Top Stories
Loading social stream, please wait...